Shares of Masimo are trading today in above average volume, with the share price falling 1.2% to $19.99. About 793,000 shares have been traded today, as compared to the 30-day average volume of 428,000 shares. Spikes in volume can validate a breakout or signify a potential turning point.
There is potential upside of 36.7% for shares of Masimo based on a current price of $19.99 and an average consensus analyst price target of $27.33. Masimo shares should first meet resistance at the 50-day moving average (MA) of $20.53 and find additional resistance at the 200-day MA of $21.51.
In the past 52 weeks, shares of Masimo have traded between a low of $17.62 and a high of $35.15 and are now at $19.99, which is 13% above that low price. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.2% while the 200-day MA has slid 0.2%.
Masimo Corporation designs, develops and licenses medical signal processing and sensor technology for the noninvasive monitoring of physiological parameters. The Company's first products are designed to improve the effectiveness of pulse oximetry by overcoming the inability of current monitors to precisely measure the levels of arterial blood oxygen saturation and low arterial blood flow.